{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:13:03Z","timestamp":1790140383339,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Sleep Medicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.5664\/jcsm.10092","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T14:01:46Z","timestamp":1655215306000},"page":"2237-2246","source":"Crossref","is-referenced-by-count":11,"title":["Exploring the impact of excessive daytime sleepiness caused by obstructive sleep apnea on patient and partner quality of life: a time trade-off utility study in the UK general public"],"prefix":"10.1007","volume":"18","author":[{"given":"Keith","family":"Tolley","sequence":"first","affiliation":[{"name":"Tolley Health Economics, Buxton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Noble-Longster","sequence":"additional","affiliation":[{"name":"Tolley Health Economics, Buxton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Mettam","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hibbs","sequence":"additional","affiliation":[{"name":"Tolley Health Economics, Buxton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cawson","sequence":"additional","affiliation":[{"name":"Tolley Health Economics, Buxton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Stainer","sequence":"additional","affiliation":[{"name":"Tolley Health Economics, Buxton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Snell","sequence":"additional","affiliation":[{"name":"Tolley Health Economics, Buxton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Manuel","sequence":"additional","affiliation":[{"name":"University Hospital Aintree, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00505"},{"key":"e_1_3_3_3_2","volume-title":"International Classification of Sleep Disorders.","author":"American Academy of Sleep Medicine","year":"2014","unstructured":"American Academy of Sleep Medicine . International Classification of Sleep Disorders. 3rd ed. Darien, IL : American Academy of Sleep Medicine ; 2014 .","edition":"3"},{"issue":"8","key":"e_1_3_3_4_2","first-page":"1311","article-title":"Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea","volume":"7","author":"Franklin KA","year":"2015","unstructured":"Franklin KA , Lindberg E . Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea . J Thorac Dis. 2015 ; 7 ( 8 ): 1311 \u2013 1322 .","journal-title":"J Thorac Dis."},{"key":"e_1_3_3_5_2","unstructured":"National Health Service (NHS\n). Excessive daytime sleepiness (hypersomnia); \n2020\n. \nhttps:\/\/www.nhs.uk\/conditions\/excessive-daytime-sleepiness-hypersomnia\/\n. Accessed July 8 2022."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/24.1.96"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15081588"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsmc.2019.08.001"},{"key":"e_1_3_3_9_2","unstructured":"UK Government\n. Obstructive sleep apnoea and driving. \nhttps:\/\/www.gov.uk\/excessive-sleepiness-and-driving\n. Accessed July 14 2022\n."},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/2040622315590318"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.5.565"},{"key":"e_1_3_3_12_2","unstructured":"British Lung Foundation (BLF)\n. Treatment for OSA; \n2019\n. \nhttps:\/\/www.blf.org.uk\/support-for-you\/obstructive-sleep-apnoea-osa\/treatment\n. Accessed July 8 2022."},{"key":"e_1_3_3_13_2","unstructured":"National Health Service (NHS)\n. Sleep apnoea. \nhttps:\/\/www.nhs.uk\/conditions\/sleep-apnoea\/\n; \n2019\n. Accessed December 4 2019."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00016808"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12039"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/28.4.464"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.05.013"},{"key":"e_1_3_3_18_2","unstructured":"Sunosi\u2122 (solriamfetol) tablets Prescribing Information\n. Palo Alto CA: Jazz Pharmaceuticals Inc; \n2019\n."},{"key":"e_1_3_3_19_2","unstructured":"Sunosi\u2122 (solriamfetol) tablets Summary of Product Characteristics\n. Dublin Ireland: Jazz Pharmaceuticals Ltd; \n2020\n."},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202002-136OC"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201806-1100OC"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-013-0508-x"},{"key":"e_1_3_3_23_2","unstructured":"National Institute for Health and Care Excellence (NICE)\n. Guide to the methods of technology appraisal; \n2013\n. \nhttps:\/\/www.nice.org.uk\/process\/pmg9\/chapter\/foreword. Accessed November 2 2020."},{"key":"e_1_3_3_24_2","unstructured":"Johns\nM\n. About the ESS. \nhttps:\/\/epworthsleepinessscale.com\/about-the-ess\/\n. Accessed January 26 2021\n."},{"key":"e_1_3_3_25_2","unstructured":"National Institute for Health and Care Excellence (NICE)\n. Obstructive sleep apnoea syndrome: How should I assess a person with suspected obstructive sleep apnoea syndrome? \nhttps:\/\/cks.nice.org.uk\/topics\/obstructive-sleep-apnoea-syndrome\/diagnosis\/assessment\/\n. Accessed August 12 2020\n."},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-019-02117-9"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001031"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-018-0045-6"},{"key":"e_1_3_3_29_2","unstructured":"Brazier\nJ Longworth\nL\n. NICE DSU Technical Support Document 8: An Introduction to the Measurement and Valuation of Health for NICE Submissions; \n2011\n. London: National Institute for Health and Care Excellence (NICE) \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK425820\/pdf\/Bookshelf_NBK425820.pdf\n. Accessed July 11 2022."},{"key":"e_1_3_3_30_2","unstructured":"Tolley\nK\n. What are health utilities? \nhttps:\/\/www.whatisseries.co.uk\/product\/what-are-health-utilities\/\n. Accessed July 8 2022."},{"key":"e_1_3_3_31_2","unstructured":"Office for National Statistics\n. UK population. \nhttps:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/bulletins\/annualmidyearpopulationestimates\/mid2020#age-structure-of-the-uk-population\n. Accessed July 14 2022."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/19.7.583"},{"issue":"4","key":"e_1_3_3_33_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3310\/hta13040","article-title":"Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis","volume":"13","author":"McDaid C","year":"2009","unstructured":"McDaid C , Griffin S , Weatherly H , et\u00a0al . Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis . Health Technol Assess. 2009 ; 13 (4): iii-iv, xi-xiv, 1-119 , 143 \u2013 274 .","journal-title":"Health Technol Assess."},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-012-0419-2"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-021-00302-6"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-015-0377-3"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2012.712927"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-12-48"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:04:08Z","timestamp":1770109448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.10092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.5664\/jcsm.10092"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.10092","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}